Molecular Diagnostics Market is Expected to Grow more than US$ 10 Billion By 2023

The molecular diagnostics market is expected to exceed more than US$ 10 Billion by 2023 growing at around 9% CAGR during the forecast period.

New York, November 19, 2018: Molecular diagnostics is a way of performing a diagnostic test to discover ailment, circumstance or infection in an artificial surroundings. Molecular diagnostic is one of the principal segments of in-vitro diagnostics marketplace. Molecular diagnostics is used to measure and stumble on the presence of genetic fabric related to specific disorder. It is used to identify DNA and RNA at molecular stage. Molecular diagnostics is a device to improve clinical effects and clinical decisions. Molecular diagnostic consists of all exams used to become aware of a disorder, by analyzing molecules such as DNA, protein or RNA in a fluid or tissue. In recent times molecular diagnostics is utilized in early detection of infectious sicknesses, most cancers and genetic ailment, by way of the usage of molecular and genetic technologies. Molecular diagnostics is likewise utilized in detection of abnormalities in pre-natal stage. Further, molecular diagnostic kits are utilized in pharmacogenetics trying out and blood donor screening.

The molecular diagnostics market is expected to exceed more than US$ 10 Billion by 2021 growing at around 9% CAGR during the forecast period.

You Can Browse Full Report @:

Market Research Engine has published a new report titled as “Molecular Diagnostics Market by Application, Technology (PCR, Microarray, DNA Sequencing), End User (Hospital, Laboratories), Product (Instruments, Reagent, Software) - Forecast to 2023”.

The Molecular diagnostics Market has been segmented as below:

The Molecular diagnostics Market is Segmented on the lines of Application Analysis, Product and service Segment Analysis, Technology Analysis, End-user Analysis and Regional Analysis. By Application Analysis this market is segmented on the basis of Infectious Diseases, Oncology, Genetics, Blood Screening, Microbiology and Others (Cardiovascular Diseases, Neurological Diseases, and DNA Fingerprinting). By Product and service Segment Analysis this market is segmented on the basis of Instruments, Reagents and Services & Software.

By Technology Analysis this market is segmented on the basis of Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), Hybridization, DNA Sequencing and Next-generation Sequencing, Microarrays and Others (Mass Spectrometry, Flow Cytometry, and Electrophoresis). By End-user Analysis this market is segmented on the basis of Reference Laboratories sector, Hospital Laboratories sector and Others (Blood Banks, Local Public Health Laboratories, Home Health Agencies, Nursing Homes, Point-of-care Settings, and Self-testing) sector. By Regional Analysis this market is segmented on the basis of North America, Europe, Asia-Pacific and Rest of the World.

Report Scope:

The scope of the report includes a detailed study of global and regional markets for various types of molecular diagnostics with the reasons given for variations in the growth of the industry in certain regions.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Roche Diagnostics (U.S.), QIAGEN N.V. (Netherlands), Hologic Inc. (U.S.), Grifols (Spain), Abbott Laboratories (U.S.), Siemens Healthcare (Germany), Becton, Dickinson and Company (U.S.), Beckman Coulter Inc. (U.S.), bioMérieux SA (France), and Cepheid Inc. (U.S.). Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

Request Sample Report from here:


Table of Contents


2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Molecular Diagnostics Market Overview

6 Molecular Diagnostics Market, By Application

7 Molecular Diagnostics Market, By Technology

8 Molecular Diagnostics Market, By Products and Services

8.1 Introduction
8.2 Reagents & Kits
8.3 Instruments
8.4 Software & Services

9 Molecular Diagnostics Market, By End User

10 Molecular Diagnostics Market, By Region

11 Competitive Landscape

12 Company Profiles

12.1 Introduction

12.2 Abbott Laboratories

12.3 Qiagen N.V.

12.4 Roche Diagnostics

12.5 Hologic, Inc.

12.6 Grifols

12.7 Siemens Healthcare

12.8 Becton, Dickinson and Company

12.9 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation)

12.10 Biomérieux Sa

12.11 Cepheid Inc.

Other Related Market Research Reports:

Minimally Invasive Medical Robotics Market is Determined to Cross US$ 44 Billion by 2022

Medical Tourism Market is Projected to Reach US$ 54.00 Billion by 2022

Medical Waste Management Market is Supposed to Reach US$ 21.00 Billion by 2024

Contact Info:
Name: John Bay
Email: Send Email
Organization: Market Research Engine

Release ID: 446257